Tickers

1. Composite Trajectory Verdict

All three statements carry weight for this capital-intensive, acquisition-driven civil infrastructure company: the income statement shows operating leverage gains, the cash flow statement reveals whether operations fund growth or rely on debt, and the balance sheet tracks leverage and goodwill concentration from the roll-up strategy.

Composite Trajectory: Mixed

Revenue, gross profit, operating income, and operating cash flow all grew strongly year-over-year (FY2025 vs. FY2024), with expanding gross (15.6% vs. 14.2%) and operating (8.0% vs. 6.1%) margins (10-K 2025-09-30, Consolidated Statements of Comprehensive Income). However, net income growth (47.6% to $101.8M) lagged operating income growth (102% to $224.8M) because interest expense surged 374% to $90.4M after the $850M Term Loan B funded the Lone Star acquisition (10-K 2025-09-30, MD&A). Total debt tripled to $1.63B, raising the covenant net leverage ratio from 1.81x to 3.10x (10-K 2025-09-30, Liquidity). Goodwill ballooned to $943M (29% of assets) from $232M (10-K 2025-09-30, Consolidated Balance Sheets). Operating cash flow rose 39% to $291M and free cash flow to $153M, but the company remains dependent on debt issuance ($1.24B in FY2025) to fund acquisitions (10-K 2025-09-30, Consolidated Statements of Cash Flows).

2. Red Flags

• Interest expense surge: Net interest expense jumped from $19.1M (FY2024) to $90.4M (FY2025), a 374% increase, consuming 40% of operating income vs. 17% prior year (10-K 2025-09-30, Consolidated Statements of Comprehensive Income).
• Debt tripling: Total long-term debt rose from $515M to $1.63B (216% increase) in one year to fund $1.5B of acquisitions (10-K 2025-09-30, Note 11 - Debt).
• Covenant leverage approaching step-downs: Consolidated net leverage ratio rose from 1.81x to 3.10x; the maximum permitted steps down to 4.25x by March 31, 2026, 4.00x by Dec 31, 2026, and 3.75x by Sept 30, 2027 (10-K 2025-09-30, Liquidity).
• Goodwill concentration: Goodwill grew 307% to $943M, representing 29% of total assets ($3.24B) at Sept 30, 2025, up from 15% ($232M/$1.54B) a year earlier (10-K 2025-09-30, Consolidated Balance Sheets; Note 9).
• Acquisition-related expenses recurring: Acquisition-related expenses hit $25.9M in FY2025 vs. $3.9M in FY2024 and $0.4M in FY2023, with transformative acquisition expenses (non-GAAP add-back) of $21.8M vs. $1.5M (10-K 2025-09-30, MD&A reconciliation tables).
• GAAP/non-GAAP gap widening: Adjusted EBITDA exceeded net income by $322M in FY2025 ($424M vs. $102M) vs. $152M gap in FY2024 ($221M vs. $69M) (10-K 2025-09-30, MD&A reconciliation tables).
• Accrued expenses spike: Accrued expenses and other current liabilities rose 161% to $110.2M from $42.2M, including $44.3M estimated fair value of working capital payable for the Lone Star acquisition (10-K 2025-09-30, Note 10; Note 4).
• Contracts receivable growth outpacing revenue: Contracts receivable including retainage grew 57% to $550M vs. 54% revenue growth, with retainage at $67M (10-K 2025-09-30, Note 5).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Revenue increased 54.2% to $2.81B in FY2025 from $1.82B in FY2024, including $835M from acquisitions and ~$153M (8.4%) organic growth (10-K 2025-09-30, MD&A). Gross margin expanded to 15.6% from 14.2%, and operating margin to 8.0% from 6.1% (10-K 2025-09-30, Consolidated Statements of Comprehensive Income). However, net income rose only 47.6% to $101.8M because interest expense climbed to $90.4M from $19.1M, and acquisition-related expenses jumped to $25.9M from $3.9M (10-K 2025-09-30, Consolidated Statements of Comprehensive Income). Diluted EPS grew 40% to $1.84 from $1.31, diluted by share issuance for the Lone Star acquisition (3M Class A shares) and a higher share count (10-K 2025-09-30, Note 13). The effective tax rate fell slightly to 24.3% from 25.1% (10-K 2025-09-30, MD&A).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Improving

Net cash from operating activities rose 39% to $291.3M in FY2025 from $209.1M in FY2024 (which was up 33% from $157.2M in FY2023) (10-K 2025-09-30, Consolidated Statements of Cash Flows). Capital expenditures increased to $137.9M from $87.9M, yielding free cash flow (operating minus capex) of $153.4M, up 27% from $121.1M (10-K 2025-09-30, Consolidated Statements of Cash Flows). Cash conversion (operating cash flow / net income) was 2.9x in FY2025 vs. 3.0x in FY2024. Investing cash outflows were dominated by $1.16B of acquisition spending (vs. $232M in FY2024), financed by $1.24B of debt proceeds (net of issuance costs) and $147M of debt repayments (10-K 2025-09-30, Consolidated Statements of Cash Flows). Ending cash and restricted cash doubled to $159M from $77M (10-K 2025-09-30, Consolidated Statements of Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Total assets more than doubled to $3.24B at Sept 30, 2025 from $1.54B at Sept 30, 2024, driven by $709M of acquisition goodwill, $523M of PP&E additions (largely from acquisitions), and $200M higher contracts receivable (10-K 2025-09-30, Consolidated Balance Sheets; Note 4; Note 8). Total liabilities jumped to $2.33B from $968M, with long-term debt (net of current portion and issuance costs) rising to $1.57B from $487M (10-K 2025-09-30, Consolidated Balance Sheets). Stockholders' equity increased to $912M from $574M, boosted by $236M of Class A stock issued for the Lone Star acquisition and $102M of retained earnings (10-K 2025-09-30, Consolidated Statements of Stockholders' Equity). The current ratio held near 1.6x (1.61x vs. 1.54x). The covenant interest coverage ratio fell to 5.76x from 11.32x but remained well above the 3.00x minimum (10-K 2025-09-30, Liquidity).

6. Data Gaps

• Quarterly GAAP revenue, gross profit, operating income, net income, and EPS for Q3 FY2025 (period ended 2025-06-30), Q1 FY2026 (2025-12-31), Q2 FY2026 (2026-03-31), and Q3 FY2026 (2026-06-30) — the 10-Q filings are listed but their financial statement tables are not included in the provided text.
• Quarterly operating cash flow, capex, and free cash flow for the same four quarters.
• Quarterly balance sheet items (debt, cash, receivables, goodwill, leverage ratios) for the four quarterly periods.
• Organic revenue growth rate for FY2026 year-to-date (cannot be derived without quarterly filings).
• Full-year FY2026 guidance or actuals (only FY2026 capex guidance of $165–185M is disclosed in the 10-K).
• Measurement period adjustments for the five FY2025 acquisitions (noted as provisional; finalization within 12 months of each acquisition date per Note 4).